MSK Report News

Thursday, January 28, 2010 Pain: Pain Pumps May Lead to Development of Chondrolysis
Hundreds of patients have developed the relatively rare ailment after the use of postsurgical pain pumps...

Wednesday, January 27, 2010 Arthritis: RA Development Can Be Predicted by Inflammatory Cytokines
Increased concentrations of proinflammatory cytokines can predict onset of RA before symptoms develop...

Tuesday, January 26, 2010 BioPharm Business News and Perspectives: FDA Approves Tocilizumab for Refractory RA
Tocilizumab (Actemra) has been approved for adults with moderate-to-severe RA who have not achieved adequate response with other TNF therapies...

Thursday, December 03, 2009 Weekly Roundup: In the News This Week
Read what MSKreport has been tweeting about this week...

Wednesday, December 02, 2009 BioPharm Business News and Perspectives: OxyPharma's New RA Drug Shows Positive Phase II Results
Rabeximod, an orally-administered DMARD, showed promise as a new RA treatment during a 16-week study...

Tuesday, November 24, 2009 Arthritis: Fatigue Is Valid Marker of RA Treatment Response
Single-item measures of fatigue are reliable and sensitive to change in RA patients taking TNF-blockers...

Thursday, November 19, 2009 BioPharm Business News and Perspectives: French Government Buys Into Naproxinod
NicOx has submitted an NDA for naproxinod for osteoarthritis, and is raising $149 million for the launch...

Wednesday, November 18, 2009 BioPharm Business News and Perspectives: FDA Wants Pain Pump Label Warnings
Chondrolysis follows continuous intra-articular local anesthetic infusion, FDA says...

Tuesday, November 17, 2009 Arthritis: Inflammation in RA Linked to Arterial Stiffness
RA patients with high inflammatory burden are more likely to have arterial stiffness, even without other known cardiovascular risk factors...

Thursday, November 12, 2009 BioPharm Business News and Perspectives: Bristol Set to Challenge Roche for RA IL-6 Blockers
Bristol-Myers Squibb has licensed RA indications for Alder's ALD518 anti-IL-6 monoclonal...